Related Experiment Video
Updated: Sep 18, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Diagnostic Challenges and Risk Stratification of Periprosthetic Joint Infection in Patients with Inflammatory
Paweł Kasprzak1,2, Wiktoria Skała3, Mariusz Gniadek2
1Department of Orthopedics and Traumatology, Medical University of Warsaw, 4 W.H. Lindleya St, 02-005 Warsaw, Poland.
Diagnosing periprosthetic joint infection (PJI) in inflammatory arthritis (IA) is difficult. New biomarkers like BPI and ELA-2 show promise for improved PJI detection in IA patients.
Area of Science:
- Orthopedic Surgery
- Rheumatology
- Infectious Diseases
Background:
- Accurate periprosthetic joint infection (PJI) detection is challenging in inflammatory arthritis (IA) patients, including rheumatoid arthritis (RA).
- Overlapping inflammatory parameters and immunosuppressive therapies complicate PJI diagnosis in IA.
Purpose of the Study:
- To review current diagnostic challenges and emerging biomarkers for PJI in patients with IA.
- To identify strategies for improving PJI diagnosis in this complex patient population.
Main Methods:
- A narrative review of PubMed/MEDLINE literature from 2010-2025.
- Search terms included "periprosthetic joint infection", "inflammatory arthritis", "rheumatoid arthritis", "diagnosis", "biomarkers", "synovial fluid", and "immunosuppression".
- 50 studies were included in the final analysis.
Main Results:
- IA patients with PJI are often younger, female, with higher comorbidity burden, and increased false-positive histology and culture-negative infections.
- Standard biomarkers (serum CRP, ESR, synovial fluid WBC, and PMN%) have low to moderate diagnostic value in IA, with different optimal thresholds than MSIS.
- Alpha-defensin shows superior performance; novel markers (serum BPI, ELA-2, synovial CRP, calprotectin) and PCR show increasing potential.
Conclusions:
- Disease and treatment confounders significantly hinder PJI diagnosis in IA patients.
- IA-specific diagnostic approaches and adjusted biomarker thresholds are necessary.
- Emerging biomarkers, particularly BPI, ELA-2, and synovial CRP, warrant further validation for improved PJI detection and perioperative management.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pericarditis II: Clinical Features and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

